Search
  • Search


    Clinical Trial Readiness through the Establishment of a Pilot Filovirus Investigational Vaccine Reserve

    Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency

    Clinical Trial Readiness through the Establishment of a Pilot Filovirus Investigational Vaccine Reserve

    1. Planning notice published

      Mar 23, 8:10 AMMarch 23, 2026 8:10 AM
    2. Change in planning

      Mar 25, 9:40 AMMarch 25, 2026 9:40 AM
    3. Planned competition start

      May 18, 12:00 AMMay 18, 2026 12:00 AM

    Brief

    Belgium: Tenders/Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency/Clinical Trial Readiness through the Establishment of a Pilot Filovirus Investigational Vaccine Reserve

    Planned

    The competition has not been announced yet.

    Deadline
    May 18,Expired
    Agreement
    Buying services
    Estimated value
    €16Mover 4 years

    Brief

    Health and Digital Executive Agency (HaDEA) is van plan om diensten aan te schaffen voor de voorbereiding op klinische proeven voor Filovirus-uitbraken, door een EU-gebaseerde reserve van onderzoeksvaccins tegen Marburg (MARV) en/of Ebola Sudan (SUDV) op te zetten, te testen en te onderhouden. Het doel is om de snelle inzet van kandidaat-vaccins voor hun latere ontwikkelingsfase (fase 2 en verder) te waarborgen. De maximale totale contractwaarde is 16.000.000 EUR voor een duur van 4 jaar.

    Forsknings- og utviklingsvirksomhet og tilhørende konsulenttjenester

    Custom Assessment Criteria

    • Get answers to your bid/no-bid criteria

      Set them up once and Cobrief answers them in every tender

    Will you bid?

    The agent sets up the bid and writes the first draft. Free for 14 days.

    Previous winners

    • Who are you up against?

      The suppliers who have won similar contracts at Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency

    From the notice

    • This call for tenders aims to ensure clinical trial preparedness for Filovirus outbreaks through the establishment of an EU-based reserve of investigational vaccines as a critical preparedness measure, given the sporadic yet high-consequence nature of these pathogens. Specifically, the call aims to establish, pilot and maintain an investigational reserve of Filovirus candidate vaccines against Marburg (MARV) and/or Ebola Sudan (SUDV), which – in case of an outbreak – could be used to advance their development by embedding them in outbreak-associated clinical trials, facilitated through international agreements and frameworks to support such preparedness. These provisions will allow for the rapid deployment of candidate vaccines for their later-stage development (phase 2 onwards). Tenderers will further have to ensure the rapid deployment of the investigational doses, subject to specific conditions being met (such as the occurrence of an outbreak and the expressed consent of the Contracting Authority).

    • Contact

      hadea-procurement@ec.europa.eu
    • Type
      Planning
    • Main code
      Research and experimental development services
      73100000
    • 73120000Experimental development services

    Similar active competitions

    • Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency

      Forskning og utdanning

      Facilitating the implementation of decentralised manufacturing for biotech medicinal products

      Health and Digital Executive Agency (HaDEA) is planning the procurement of services to facilitate the implementation of decentralised manufacturing for biotech medicinal products, with an estimated maximum total contract value of 3,000,000 EUR over 3 years. The purpose is to support developers of biotech medicinal products in implementing a new decentralised procedure manufacturing set-up for their products.

      Planning
      Feb 2, 2027(96 days)
      €3,000,000
    • Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency

      Dekk og biltilbehør

      Capacity Reservation for Personal Protective Equipment Pilot

      The Health and Digital Executive Agency (HaDEA) in Belgium needs services for the reservation of manufacturing capacity and contractor-managed stockpiles of nitrile examination gloves (lot 1) and FFP2 respiratory masks (lot 2) for a duration of 3 years, with a maximum total value of 34,000,000 EUR. The purpose is to enhance the accessibility and availability of Medical Counter-Measures (MCMs) in the EU/EEA, with the contractor required to have manufacturing capacity within the EU/EEA. The contracting authority and/or the European Commission will have the right to purchase the stockpiled or manufactured MCMs for preparedness or crisis purposes. Each lot will be awarded to a maximum of three tenderers. Award criteria are Quality (60%) and Price (40%).

      Competition
      Dec 8, 2026(40 days)
      €34,000,000